Briumvi’s claim to fame is its dosing schedule: a 1-hour every 24 weeks, after the loading-dose regimen of a 4-hour infusion and a 1-hour infusion two weeks later.
And the fact that it binds to an antigenically distinct epitope
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.